Previous work has demonstrated less accurate alignment of cortical structures for patients with schizophrenia than for matched control subjects when using affine registration techniques. Such a mismatch presents a potential confound for functional neuroimaging studies conducting between-group comparisons. Critically, the same issues may be present for subcortical structures. However, to date no study has explicitly investigated alignment precision for major subcortical structures in patients with schizophrenia. Thus, to address this question we used methods previously validated for assessment of cortical alignment precision to examine alignment precision of subcortical structures. In contrasts to our results with cortex, we found that major subcortical structures (i.e. amygdala, caudate, hippocampus, pallidum, putamen and thalamus) showed similar alignment precision for schizophrenia (N = 48) and control subjects (N = 45) regardless of the template used (other individuals with schizophrenia or healthy controls). Taken together, the present results show that, unlike cortex, alignment for six major subcortical structures is not compromised in patients with schizophrenia and as such is unlikely to confound between-group functional neuroimaging investigations.
Introduction
A major challenge for most fMRI studies investigating functional differences between clinical and healthy populations is optimal alignment of anatomical and functional data across individuals, especially if there are reasons to believe that within-group alignment may be compromised in the clinical sample. Currently, most fMRI studies in schizophrenia use volumetric representations for data analysis (Acton and Friston, 1998; Friston et al., 1995; Worsley and Friston, 1995) and apply volume-based registration (VBR) to compensate for inter-individual variability in brain anatomy (Woods et al., 1998a,b) . Previously, we demonstrated that affine VBR may not be the optimal strategy for cortical alignment, possibly due to a mismatch between volume representations and cortical geometry, which is essentially a 2D folded sheet of tissue . Importantly, we also showed less accurate cortical alignment in patients with schizophrenia vs. healthy controls when using affine VBR , possibly owing to subtle abnormalities in cortical morphology in this illness, which may give rise to greater anatomical variability across schizophrenia subjects Shenton et al., 2001) .
The same problems may exist in patients with schizophrenia when considering subcortical alignment. To date, numerous studies have demonstrated subcortical size and shape abnormalities in this patient population for structures such as the hippocampal complex, amygdala and thalamus (Csernansky et al., 1998 (Csernansky et al., , 2004 Harms et al., 2007; Konick and Friedman, 2001; Lawrie et al., 2003; Mamah et al., 2007; Namiki et al., 2007; Shenton et al., 2001 Shenton et al., , 2002 Velakoulis et al., 1999 Velakoulis et al., , 2006 Wang et al., 2008; Wood et al., 2001) . While these differences in brain morphology may be a consequence of the disease process and clinically significant in their own right, they further complicate functional investigations of these same regions. In principle, more spatial heterogeneity and smaller average size of subcortical structures could reduce alignment precision in the same way as demonstrated for cortical structures Van Essen, 2005) . In turn, as shown for cortical activations, lack of precise anatomical alignment may result in loss of statistical power when conducing fMRI analyses Argall et al., 2006; Desai et al., 2005; Fischl et al., 1999a,b) . Moreover, an exaggerated reduction in alignment precision in individuals with schizophrenia could further reduce power to detect significant task-related activation when compared to controls, which introduces a confound in the comparison of patients to healthy controls. Thus, some apparent differences in functional activation could arise from power discrepancies resulting from anatomical mismatches, and not true functional abnormalities . This presents a serious concern for fMRI studies conducting between-group comparisons and consequently may impact the interpretation of fMRI results with clinical populations. However, at present it remains unclear whether subcortical alignment precision is compromised in patients with schizophrenia.
To illustrate the point above, consider studies examining amygdala activation in patients with schizophrenia. To date, there is evidence suggesting that patients with schizophrenia under-recruit the amygdala in response to affective material (Aleman and Kahn, 2005; Li et al., 2009) . As noted, some of these findings could -in theory -reflect reduced amygdala alignment fidelity for patients with schizophrenia when compared to healthy controls. As shown for cortical activations, reductions in amygdala alignment in patients could lead to reduced estimates of amygdala activation. Therefore, reduced alignment could, in principle, produce a positive finding of amygdala under-recruitment in patients when compared to controls, which would actually arise from an artifact of reduced alignment fidelity in the clinical sample. The same concerns are not limited to the amygdala, and logically extend to other subcortical structures. However, to our knowledge, no study to date has explicitly investigated subcortical alignment profiles in patients with schizophrenia and verified whether this confound can be ruled out when examining activation differences in major subcortical areas.
To address these questions, we examined subcortical alignment precision in six major subcortical structures for a large sample of individuals with schizophrenia and matched healthy controls.
Materials and methods

Subjects
Subjects were recruited through the clinical core of the Conte Center for Neuroscience of Mental Disorders (CCNMD) at Washington University in St. Louis. Clinical assessments were conducted by a research associate trained to administer the SCID-IV, who also regularly participated in the diagnostic rating sessions (First et al., 2002 ). An additional assessment session was conducted by an expert clinician using a semistructured interview for DSM-IV as well as all available patient records. A consensus on each diagnosis was reached between the interviewer and the expert clinician. The complete sample included 48 subjects meeting DSM-IV diagnostic criteria for schizophrenia and 45 demographically matched healthy control subjects (Table 1) . Control subjects were recruited using local advertisements in the same community from which schizophrenia subjects were recruited. Control subjects were not included if they had any lifetime history of Axis I psychiatric disorder or a firstdegree relative with a psychotic disorder. Both control and schizophrenia subjects were also excluded if they: 1) met criteria for DSM-IV substance abuse or dependence within the past 6 months; 2) they had any severe medical complications that would compromise psychiatric assessment and diagnosis or render the subject unstable or at risk to participate; 3) they suffered head injury (past or present) with manifestation of neurological symptoms or loss of consciousness; or 4) met DSM-IV diagnostic criteria of mental retardation. All schizophrenia subjects were taking antipsychotic medication at the time of the scan and had to be stable for a period of at least 2 weeks. All subjects completed and signed an informed consent approved by the Washington University IRB and were assessed for handedness using the Edinburgh Handedness Inventory (Oldfield, 1971) . Measurements of IQ (Wechsler, 1997) , medication dose (converted to chlorpromazine equivalents) and symptom severity using the Schedules for the Assessment of Positive and Negative Symptoms (Andreasen, 1983a,b) were also obtained for each subject and their possible relationship with alignment quality was explored.
Scanning
All subjects were scanned at the Washington University Medical School. The structural images from the participants were obtained from either a 1.5 T Siemens VISION system (29 patients and 27 controls) or a 3 T Tim TRIO system (19 patients and 18 controls). Although there could be concerns about combining data from different scanner platforms, the number of subjects in schizophrenia vs. control group scanned at either 1.5 T and 3 T data were similar (meaning that group was not confounded with scanner platform) and there was no interaction between the group factor and scanner platform (see Results). The structural images acquired on both scanners used a coronal MP-RAGE 3D T1-weighted sequence (for the 1.5 T, TR= 9.7 ms, TE = 4 ms, flip= 10°; voxel size= 1 × 1 × 1.2 mm; for 3 T, TR = 2400 ms, TE = 3.16 ms, flip = 14.5°; voxel size= 1 × 1 × 1 mm).
Volume based registration (VBR)
The entire 3D structural volume (T1) was registered to a stereotaxic atlas space (Talairach and Tournoux, 1988 ) using 12-parameter affine transform and resampled to 1 mm cubic representation (Buckner et al., 2004; Ojemann et al., 1997) . The VBR method was identical to the approach taken when examining cortical alignment and corresponds to widely used methods in the schizophrenia literature .
Subcortical structure isolation
As noted, we sought to compare alignment precision in six different bilateral subcortical structures including the amygdala, caudate, hippocampus, pallidum, putamen, and thalamus. To this end, we isolated each subject's bilateral structure using an automated subcortical segmentation algorithm implemented in the FreeSurfer software package (http:// surfer.nmr.mgh.harvard.edu/), which was shown to have high reliability when compared to manual subcortical identification (Fischl et al., 2002 (Fischl et al., , 2004 . Also, other authors have found comparable results between FreeSurfer and manual anatomical ratings in a clinical population (Tae et al., 2008) . Subcortical binary masks for each structure were isolated using in-house algorithms and used for subsequent analyses. Results were visualized using the AFNI software package (Cox, 1996) . Of note, no between-group volume differences across structures were found (all ps N 0.3). In addition, the two groups were compared in terms of equality of variances for each structure and each hemisphere. The only significant difference that emerged was in the left thalamus, which however did not show alignment differences between the groups (see Results).
Volume alignment precision
To quantitatively evaluate subcortical alignment a rigorously validated metric for volume alignment precision (VAP) was used. The VAP metric is similar to the volume alignment consistency (VAC) and surface alignment consistency (SAC) measures introduced by Van Essen (2005) , but has the advantage of allowing parametric statistical comparisons, as it computes a quantitative measure of overlap for each subject. Briefly, to obtain the VAP index, identified subcortical structures for each subject were summed to generate probabilistic maps that reflected, for each voxel, the number of subjects for whom that voxel was in the subcortical structure of interest (i.e. an overlap histogram). We then selected those voxels for a given structure that were labeled as belonging to that subcortical region for at least 50% of subjects. Next, the intersection between each individual subject's mask for that structure and the group 50% overlap region for a particular structure was expressed as a fraction of the individual subject's total structure volume and then averaged across all subjects, yielding the VAP for that structure:
where x(s) is the number of voxels in a given structure (s) for subject i that intersect the 50% overlap region; x(total) is the total number of voxels that belong to structure s for subject i; and n is the total number of subjects contributing to the VAP calculation. As shown previously, the 50% overlap criterion was fairly stringent and was likely to detect true betweengroup alignment differences .
Results
First, in order to qualitatively visualize the results of within-group alignment we generated the probabilistic overlap maps shown in Fig. 1 . The red voxels mark locations of high overlap in a given structure, whereas the blue voxels mark areas of low overlap. Upon visual inspection, there are no discernible alignment precision differences between schizophrenia (left panel) and control subjects (right panel) for any of the examined structures (Fig. 1A-L) . Next, we verified these results quantitatively using the VAP index. Fig. 2 shows the average VAP indices for both hemispheres separately as well as bilaterally for all examined structures ( Fig. 2A-F) . In line with the probabilistic maps shown in Fig. 1 , the VAP measures showed numerically small differences between schizophrenia and control subjects. To confirm this statistically, we computed a 3-way ANOVA with one betweengroup factor (Group, 2 levels -schizophrenia and control subjects) and 2 within-group factors (Hemisphere, 2 levelsleft and right; Region, 6 levels). The ANOVA results indicated no main effect of Group In addition to the statistical comparisons, we quantified the degree of between-group differences observed for each structure using effect size calculations (i.e. Cohen's d) (Cohen, 1992) . Table 2 shows effect sizes for differences between schizophrenia and control VAP indices for each structure and hemisphere. The average effect size across both hemispheres and all structures was 0.14, which by standard convention would be considered a negligible effect (Cohen, 1992) . Furthermore, 10/18 individual comparisons had negligible effect sizes (i.e. Cohen's d less than 0.15) and no effect size exceeded the value of 0.4, thus falling below the lower cutoff for what would conventionally be considered a medium effect. Taken together, these results suggest minimal VAP differences between schizophrenia and control subjects when using affine registration techniques.
Although the above analysis demonstrates equivalent within-group alignment, it does not verify whether the across-group alignment is adequate. In other words, it is critical to show that schizophrenia subjects align at least approximately as well to the control subjects as they do to themselves. We examined this question by using the 50% overlap region from the control sample as the intersection volume when computing the VAP for the schizophrenia group (see Materials and methods section). Fig. 2 (light gray bars) indicate that the results remain largely unchanged when using schizophrenia subjects' anatomies and the control 50% overlap template. To verify this statistically, we computed a 3-way ANOVA identical to that used for the within-group VAP scores. The ANOVA results indicated no main effect of Group Table 2 ). The average effect size was 0.12, which would again be considered negligible by standard convention. Moreover, no effect size calculations exceeded 0.25 and 10/18 fell in the negligible range (i.e. Cohen's d smaller than 0.15), confirming that subcortical VAP for schizophrenia subjects remains similar even when using the 50% overlap region derived from the control group.
In addition, we examined whether medication status, IQ, or symptom severity impacted the quality of alignment precision in the patient group. The average correlation across all structures for the left and right hemisphere between medication dose and alignment precision was r = 0.06 and r = − 0.02 respectively. When examining each structure separately, only one correlation emerged at p b 0.05 level in the left caudate (r = − 0.31). However, given the number of comparisons this finding would not survive even a liberal multiple-comparison correction. The average correlation across all structures for the left and right hemisphere between IQ and alignment precision was r = 0.26 and r = 0.15 respectively. When examining each structure separately no correlations were significant at p b 0.05. In addition, we calculated symptom severity based on SAPS and SANS ratings and correlated the obtained values with alignment precision across left and right hemispheres in three broad 
Discussion
We demonstrate, using the same techniques previously applied to cortical regions, that subcortical alignment in patients with schizophrenia is comparable to that of control subjects when using 12-parameter affine VBR. Furthermore, we cross-validate these results across groups, demonstrating that, when using the control subjects' derived overlap region, results change minimally as compared to schizophrenia within-group alignment.
Subcortical versus cortical alignment
The main finding in the current study is relatively similar alignment of subcortical structures in schizophrenia and control subjects, supported by negligible effect sizes when comparing group differences in alignment (Cohen, 1992) . Moreover, the largest observed VAP differences (right palladium and right putamen) did not reach what, by standard convention, would be considered even a medium effect size. Admittedly, this pattern of results was surprising given our previous findings for cortical landmarks . We would have expected reduced VAP for at least some subcortical structures in schizophrenia subjects given numerous reports of anatomical and morphological abnormalities in some of the investigated regions (Csernansky et al., 1998 (Csernansky et al., , 2004 Harms et al., 2007; Konick and Friedman, 2001; Lawrie et al., 2003; Mamah et al., 2007; Namiki et al., 2007; Shenton et al., 2001 Shenton et al., , 2002 Velakoulis et al., 1999 Velakoulis et al., , 2006 Wang et al., 2008; Wood et al., 2001) . One possible explanation for our findings may be the inherent geometry of subcortical relative to cortical anatomy. In other words, given that cortex is a 2D folded sheet of tissue, most cortical landmarks take the geometric representations of 'ribbons' or folded 'sheets' in 3D space with high surface-tovolume ratio. In turn, any type of movement (i.e. translation or rotation) or distortion (i.e. subtle anatomical shape abnormalities) will have a large impact on alignment of such a brain region relative to the group average. In contrast, most subcortical structures have a much smaller surface-tovolume ratio and more closely approximate spherical configurations (with the possible exception of the hippocampus). In turn, closer approximation of spherical shape may render across-subject subcortical alignment more robust to subtle shape abnormalities and/or shifts in space.
Implications for fMRI studies and statistical power
It is important to note that our findings do not imply that subtle shape deformations in subcortex are not clinically important. However, our findings do suggest that alignment of subcortical structures is unlikely to confound subcortical fMRI investigations in patients with schizophrenia. There are two main pieces of supporting evidence for this assertion. First, the overall magnitude of effect size differences was negligible when directly comparing schizophrenia vs. control group alignment profiles for each structure. Second, we found that when testing across-group alignment (e.g., alignment of schizophrenia to control subjects) the results remain largely unchanged, suggesting that schizophrenia subjects' subcortical structures align relatively well with respect to control group templates. If schizophrenia subjects' anatomies were shifted or much more variable relative to the control group then the across-group alignment would have been poorer, but we failed to observe such an effect.
It should be noted that we found a Group ×Hemisphere interaction with respect to alignment precision in the withingroup alignment analyses, which indicated that schizophrenia subjects showed relatively worse alignment in the right when compared to left hemisphere structures, whereas no such finding was observed for controls. While a statistically reliable finding, the magnitude of the hemispheric alignment difference in the schizophrenia group was very small for almost all regions, and schizophrenia and control groups did not differ for either the right or the left hemisphere. Given that the only hemispheric difference approaching the medium effect size was in the right pallidum, functional neuroimaging studies examining this region may want to verify that alignment in their sample is not compromised or alternatively use a ROI-based analytic strategy that would eliminate the problem of an alignment mismatch. Of note, one possibility is that our findings reflect exaggerated hemispheric asymmetries previously reported in schizophrenia (Crow, 1999; Crow et al., 1989a,b; Pearlson and Marsh, 1999; Qiu et al., 2009; Shenton et al., 2001) , which may lead to greater alignment mismatches in certain left hemisphere subcortical structures. Finally, the present findings also suggest that subcortical alignment differences may have a negligible impact on other methods relying on similar registration techniques for aligning subcortical structures (e.g. voxel-based morphometry studies) (Modinos et al., 2009 ).
Possibility for further improvements
While we demonstrated that alignment precision shows negligible discrepancies between schizophrenia and control subjects following 12-parameter affine registration, there were still differences in specific structures that approached medium effect sizes. Such differences may be completely eliminated with current state-of-the-art subcortical segmentation techniques using structure-specific alignment. For instance, one approach -large deformation diffeomorphic metric mapping (LDDMM) of subcortical structures introduced by Khan and colleagues (Khan et al., 2008) -which is integrated with the FreeSurfer software package employs sample-specific template-based registration while producing a 'smoother' segmentation of subcortical structures. In turn, superior segmentation should further minimize acrosssubject variability for a given structure. In addition to improved segmentation, LDDMM affords non-linear structure-specific registration, which further minimizes alignment discrepancies and should, in principle, yield an even better power profile for functional neuroimaging investigations. Additionally, state-of-the-art whole-brain non-linear deformation algorithms evaluated by Klein et al. (2009) may further reduce alignment discrepancies observed in the current study.
Limitations
We demonstrated that VAP for major subcortical structures is largely equivalent in schizophrenia and control subjects. However, we did not explicitly examine the relationship between VAP and power profiles for fMRI signal within subcortical structures. The implication of the current findings is that the observed negligible effect sizes for between-group differences in subcortical alignment do not present a plausible confound for fMRI comparisons. However, it will be important for future work to explicitly test this hypothesis. Given that we focused on six major subcortical structures, it would be quite challenging to design a single experiment that reliably engages all of the examined structures in one study in the same participants. However, for future validations it would be feasible to investigate one or a few regions in focused studies (e.g. the amygdala in response to facial affect) to explicitly validate that even minimal subcortical alignment mismatches do not confound fMRI activation profiles. In addition, while we did not find alignment differences in the present study, we still cannot rule out the possibility that if we were to examine a more chronic and severe sample some differences may be more apparent.
Conclusions
In summary, we demonstrated that, in contrast to cortex, alignment of subcortical structures is largely similar when comparing patients with schizophrenia and healthy controls. This has important implications for studies examining functional differences in subcortical structures, particularly those using whole-brain approaches, as it suggests that group differences in alignment may not present a major confound for interpreting group differences in functional activation.
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